Roivant Sciences Ltd. (ROIV) NASDAQ
28.33
+0.49(+1.76%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
28.33
+0.49(+1.76%)
Currency In USD
| Market Cap | 7.32B |
| Enterprise Value | 4.7B |
| P/E Ratio | -24.4 |
| PEG Ratio | 0.22 |
| Price/Sales Ratio | 1,523.35 |
| Price/Book Ratio | 4.62 |
| Enterprise/Revenue | 1,427.87 |
| Enterprise/EBITDA | -18.72 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -60.8 |
| Operating Margin | -91.31 |
| Return On Assets | -0.15 |
| Return On Equity | -0.18 |
| Revenue | 29.05M |
| Revenue/Share | 0.02 |
| Gross Profit | 28.14M |
| EBITDA | -1.1B |
| Net Income | -171.98M |
| Diluted EPS | -0.24 |
| Total Cash | 4.53B |
| Total Cash/Share | 6.5 |
| Total Debt | 207.44M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 30.66 |
| Book Value Per Share | 7.14 |
| 52-Week Change | 183.02 |
| 52-Week High | 30.33 |
| 52-Week Low | 8.73 |
| Moving Average 50 Days | 26.51 |
| Moving Average 200 Days | 18.82 |
| Average Volume | 6.39M |
| Shares Outstanding | 715.7M |
| % Held by Institutions | 73.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |